galantamine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

galantamine has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, HZ; Dong, CZ; Ezoulin, MJ; Heymans, F; Li, J; Massicot, F; Ombetta, JE; Wu, G1
Chen, HZ; Dong, CZ; Ezoulin, MJ; Heymans, F; Lelièvre, L; Li, J; Liu, Z; Massicot, F; Ombetta, JE1

Other Studies

2 other study(ies) available for galantamine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Differential effect of PMS777, a new type of acetylcholinesterase inhibitor, and galanthamine on oxidative injury induced in human neuroblastoma SK-N-SH cells.
    Neuroscience letters, 2005, Dec-02, Volume: 389, Issue:2

    Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Encephalitis; Furans; Galantamine; Glutathione; Humans; Inflammation Mediators; Interleukin-1; Lipopolysaccharides; Mitochondria; Neuroblastoma; Neurons; Neuroprotective Agents; Oxidative Stress; Platelet Activating Factor; Reactive Oxygen Species

2005
Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairment.
    Toxicology in vitro : an international journal published in association with BIBRA, 2006, Volume: 20, Issue:6

    Topics: Cell Survival; Cholinesterase Inhibitors; Furans; Galantamine; Humans; Lipid Peroxidation; Liver; Membrane Potentials; Mitochondria; Oxidative Stress; Platelet Activating Factor; Tacrine

2006